Pages that link to "Q36342385"
Jump to navigation
Jump to search
The following pages link to Current treatment strategies for disseminated candidiasis (Q36342385):
Displaying 50 items.
- Human dectin-1 deficiency and mucocutaneous fungal infections (Q24645008) (← links)
- Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes (Q26825342) (← links)
- Neutrophil Integrins and Matrix Ligands and NET Release (Q28074216) (← links)
- Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005 (Q28260910) (← links)
- Active and Passive Immunization with rHyr1p-N Protects Mice against Hematogenously Disseminated Candidiasis (Q28744094) (← links)
- Epidemiology of invasive candidiasis: a persistent public health problem (Q29616758) (← links)
- Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program (Q30445376) (← links)
- Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. (Q30445379) (← links)
- Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections (Q33488522) (← links)
- Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice (Q33521257) (← links)
- Synthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid) (Q33719218) (← links)
- Genetic Control of Susceptibility to Infection with Candida albicans in Mice (Q33886289) (← links)
- Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes (Q34145535) (← links)
- Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults (Q34237335) (← links)
- Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants (Q34484827) (← links)
- Study on the effect of neem (Azadirachta indica A. juss) leaf extract on the growth of Aspergillus parasiticus and production of aflatoxin by it at different incubation times (Q34724824) (← links)
- Candida parapsilosis, an emerging fungal pathogen (Q34852747) (← links)
- A surveillance of nosocomial candida infections: epidemiology and influences on mortalty in intensive care units (Q35601809) (← links)
- The β-Glucan Receptor Dectin-1 Activates the Integrin Mac-1 in Neutrophils via Vav Protein Signaling to Promote Candida albicans Clearance (Q35630015) (← links)
- Identification of an N-acetylglucosamine transporter that mediates hyphal induction in Candida albicans. (Q35650752) (← links)
- 3-(1H-Imidazol-1-yl)-1-phenyl-propan-1-ol (Q35808035) (← links)
- Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion test (Q35913918) (← links)
- Fungal infections: their diagnosis and treatment in transplant recipients (Q36206568) (← links)
- Intraluminal Release of an Antifungal β-Peptide Enhances the Antifungal and Anti-Biofilm Activities of Multilayer-Coated Catheters in a Rat Model of Venous Catheter Infection (Q36458379) (← links)
- Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. (Q36497888) (← links)
- Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole (Q36521993) (← links)
- Anidulafungin: a new echinocandin for candidal infections (Q36723788) (← links)
- Candida albicans flu1-mediated efflux of salivary histatin 5 reduces its cytosolic concentration and fungicidal activity (Q36757536) (← links)
- Nosocomial fungal infections: epidemiology, diagnosis, and treatment (Q36825717) (← links)
- The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus (Q36898452) (← links)
- Candida parapsilosis endocarditis: a comparative review of the literature. (Q36931732) (← links)
- Painful Bladder Syndrome: An Unusual Presentation in a Case of Upper Tract Fungus Balls (Q37014818) (← links)
- Candida endophthalmitis: focus on current and future antifungal treatment options (Q37015976) (← links)
- Economic evaluation of voriconazole for the treatment of candidemia in Canadian adults (Q37021364) (← links)
- In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen (Q37160845) (← links)
- Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children (Q37242216) (← links)
- Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections (Q37288766) (← links)
- Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. (Q37313053) (← links)
- Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. (Q37313058) (← links)
- Present situation in the treatment of invasive fungal infection (Q37327107) (← links)
- Treatment of critically ill patients with candidemia. (Q37327117) (← links)
- Anidulafungin: a novel echinocandin for candida infections (Q37345790) (← links)
- Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. (Q37374850) (← links)
- Vaccines to prevent systemic mycoses: holy grails meet translational realities (Q37390781) (← links)
- Warthin tumor presenting as a fungal abscess in an immunocompetent host: case report and review of the literature (Q37430112) (← links)
- Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. (Q37600532) (← links)
- Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility (Q37613000) (← links)
- Invasive candidiasis in pediatric intensive care units (Q37631486) (← links)
- Failure of Echinocandin Therapy in the Treatment of Candida glabrata Chorioretinitis (Q37952592) (← links)
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. (Q39899742) (← links)